The Trump administration is currently establishing a regulatory framework to integrate autonomous AI into the U.S. healthcare system, according to several recent national reports.
In a June 4 Washington Post article, author Elizabeth Dwoskin explores how this initiative is designed to transition AI from a supportive tool to an independent practitioner capable of diagnosing conditions and prescribing medications. These policy changes respond to the ongoing shortage of rural doctors and the rising prevalence of chronic diseases.
REGULATORY FAST TRACKS AND PILOT PROGRAMS
Federal agencies are implementing several programs to accelerate the adoption of medical AI:
- Prescription Refills: A pilot program in Utah currently utilizes AI chatbots to process prescription refills. Officials presently require human oversight, but they plan to transition to a fully autonomous AI model.
- Cardiovascular Care: The Advanced Research Projects Agency for Health (ARPA-H) is offering $50 million in awards to develop conversational AI for heart attack triage.
- FDA TEMPO Pilot: The FDA has launched a “fast track” for digital health technologies, specifically targeting AI chatbots and wearables for chronic disease management.
- Medicaid Reimbursement: New guidelines allow Medicaid to reimburse providers for the use of AI-powered wellness applications.
CLINICAL CONCERNS AND PERFORMANCE DATA
Despite the federal push, many healthcare professionals express concerns regarding the safety and reliability of autonomous systems. Critics argue that replacing human judgment with AI could lead to misdiagnoses and the erosion of clinical standards.
Research indicates a significant gap between controlled testing and real-world application. A recent study in Nature Medicine found that “chatbots determined medical conditions accurately just 34 percent of the time” (Gilbert, et al., 2026). Experts note that chatbots often struggle with “hallucinations” or providing inaccurate information to please the user.
Regarding the risks of these tools, Monica Agrawal (2026) notes in “Hidden risks of asking AI for health advice“ that “people pleasing impulses that plague chatbots can be even more dangerous in medical settings.”
THE INDUSTRY PUSH FOR INDEPENDENT AI DOCTORS
Technology firms are heavily investing in systems designed to read medical records and provide direct patient guidance. Startups like Certuma are seeking the first FDA approval for an independent AI physician. Proponents liken this transition to the development of self-driving cars, suggesting that years of real-world data will eventually prove AI safety matches or exceeds human performance.
Highlighting the risks of rapid implementation, Robert Wachter (2026) warns in “A Giant Leap: AI in the Future of Medicine“ that “at some point there will be cases where we have given the AI a level of trust that it doesn’t yet deserve, and people will get hurt and probably people will be killed.”
For eyecare professionals, these developments suggest a future where AI may handle routine triage or administrative tasks. However, the medical community remains divided on whether software can truly replicate the nuanced information gathering and subtle cue detection of a trained clinician.
Read more news from AI in Eye Care here
Author
